Physician profile
James E Kasiewicz
NPI 1619119922
$7,278.52
in general payments reported to CMS, 2019-2025
12 companies · $246 in 2025
The $246 reported for 2025 was more than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $296 · 2021: $16.90 · 2022: $42.27 · 2023: $50.11 · 2024: $6,627 · 2025: $246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,331 · Travel and Lodging: $2,696 · Food and Beverage: $897.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,331.25 |
| Travel and Lodging | $2,695.54 |
| Food and Beverage | $896.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,188.58 | 2024 | |
| Chiesi USA, INC. | $237.31 | 2019-2025 | Cleviprex |
| Ethicon US, LLC | $206.14 | 2025 | Evarrest, Surgicel Nu-Knit, Vistaseal |
| Solventum Corporation | $158.25 | 2024 | V.A.C. Dermatac, V.A.C. Veraflo, Activ.A.C. |
| Csl Behring | $145.00 | 2024 | Kcentra |
| Edwards Lifesciences Corporation | $114.69 | 2019 | |
| Kci USA, INC. | $97.63 | 2019 | |
| Inari Medical, INC. | $41.02 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Atricure, INC. | $30.75 | 2023 | |
| Stryker Corporation | $22.89 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Janssen Pharmaceuticals, INC | $19.36 | 2023 | Xarelto |
| Alexion Pharmaceuticals, INC. | $16.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Kasiewicz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.